Shuttle Pharmaceuticals Holdings (SHPH) Cash from Financing Activities (2021 - 2026)

Shuttle Pharmaceuticals Holdings' Cash from Financing Activities history runs 6 years deep, the most recent figure standing at $3.2 million for Q1 2026.

• In Q1 2026, Cash from Financing Activities fell 37.31% year-over-year to $3.2 million; the TTM figure through Mar 2026 stood at $9.0 million (up 1.43% YoY), while the FY2025 annual figure was $11.0 million, up 191.66% from the prior year.
• Cash from Financing Activities was $3.2 million for Q1 2026 at Shuttle Pharmaceuticals Holdings, up from $2.3 million in the prior quarter.
• In the past five years, Cash from Financing Activities ranged from a high of $10.1 million in Q3 2022 to a low of -$461667.0 in Q2 2024.
• Historically, Cash from Financing Activities has averaged $2.1 million across 5 years, with a median of $525715.0 in 2022.
• The sharpest annual moves came in 2023 and 2025: Cash from Financing Activities slumped 396.48% in 2023, then jumped 12898.47% in 2025.
• A 5-year view of Cash from Financing Activities shows it stood at -$67363.0 in 2022, then plunged by 396.48% to -$334444.0 in 2023, then surged by 1431.66% to $4.5 million in 2024, then tumbled by 49.05% to $2.3 million in 2025, then jumped by 41.43% to $3.2 million in 2026.
• The last three Cash from Financing Activities figures came in at $3.2 million (Q1 2026), $2.3 million (Q4 2025), and -$96375.0 (Q3 2025), per Business Quant data.